The All-In-One Screener can be used to find insider buys and sales over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying/All Insider Selling to “$1,000,000+” and duration to "October 2015."
According to the above filters, the following are the recent buys from company insiders in the past week.
On Oct. 16, Terren S. Peizer, chairman and CEO of Catasys Inc. (CATS) bought 5,410,000 shares of the company at the price of 30 cents per share with total cost of $1,623,000. Since then the price of the stock has risen by 13.30%.
The company has an institutional ownership of 65% and an insider ownership of 40%.Ă‚
The price of the stock has dropped by 85% year-to-date and is now trading with a P/S ratio of 3.40, which is the highest level in the company’s recent history. Profitability, returns and financial ratios are deeply negative, and GuruFocus gives an overall rating of 2/10 for profitability and growth and 1/10 to financial strength.
On Oct. 19, Camber Capital Management LLC, a 10% owner of Protalix Bio Therapeutics Inc. (PLX) bought 4,000,423 shares of the company at the price of $1.00 per share and a total cost of $4,000,420. Since then the price of the stock has risen by 12%.
The company has an institutional ownership of 37%. The insider ownership is 4%.
The price of the stock has dropped by 51% year-to-date and is now trading with a P/S ratio of 7.47, which is below the industry median of 13.59. Profitability, returns and financial ratios are deeply negative and GuruFocus gives a rating of 5/10 for the company's profitability and growth. Financial Strength has a rating of 4/10 with a cash to debt of 0.64 that is underperforming the industry average ratio of 71.54.
On Oct. 19, Naphtha Holding Ltd., a 10% owner of Isramco Inc. (ISRL) bought 16,000 shares of the company at the price of $120 per share and a total cost of $1,920,000. Since then the price of the stock has dropped by 25%.
The company has an institutional ownership of 4% and an insider ownership of 1%.
The price of the stock has dropped by 34% over the last 12 months and is now trading with a P/S ratio of 2.87, which is above the industry median of 1.67. GuruFocus gives the company's profitability and growth a rating of 6/10. Financial strength has a rating of 6/10 with a very weak cash to debt of 0.15.
On Oct. 20, Ray R. Irani, a director of Wynn Resorts Ltd. (WYNN) bought 40,000 shares of the company at the price of $67.99 per share with a total cost of $2,719,600. Since then the price of the stock has declined by 0.6%.
The company has an institutional ownership of 92%. The insider ownership of 21% has been steady at these levels since the first quarter of 2010.
The price of the stock has dropped by 54% year-to-date and is now trading with a P/S ratio of 1.61, which is ranked lower than 51% of its competitors. The company has a profitability and growth rating of 6/10. Financial strength has a rating of 4/10.
On Oct. 21, Edward P. Garden, director of Bank of New York Mellon Corp. (BK) bought 285,000 shares of the company at the price of $41.34 per share. Since then, the price of the stock has increased by 2.2%.
The company has an institutional ownership of 85% and an insider ownership of 1%.
The price of the stock has risen by 4% year-to-date and is now trading with a P/S ratio of 3.11. The company has a profitability and growth rating of 7/10. Returns are positive, with ROE of 6.84% ROA of 0.69%. Financial strength has a rating of 4/10 with strong cash to debt ratio of 5.01 and interest coverage of 10.06.
On Oct. 22, Glenview Capital Management, a 10% owner of Tenet Healthcare Corp. (THC) bought 500,000 shares of the company at the price of $29.71 per share. Since then, the price of the stock has increased by 0.9%.
The company has an institutional ownership of 100% and an insider ownership of 3%.
The price of the stock has dropped by 40% year-to-date and is now trading with a P/S ratio of 0.17 that is ranked higher than 96% of the company’s competitors. The company has a profitability and growth rating of 7/10. GuruFocus gives the financial strength a rating of 6/10.
